|
|
|
|
Looks like gold's catching everyone's attention again. Geof Smith, a commodities expert with nearly 20 years in the gold market, has spotted a signal for the next huge gold breakout. His charts are showing a signal he hasn't seen since 2005. The last time this happened, gold surged almost 400%. But here's the twist… He's telling people to hold off on buying gold right now. Seems counterintuitive, doesn't it? Well, Geof claims he's found a way to potentially profit even more than owning physical gold. It's a method that has the power to turn small gold moves into what could be much bigger gains. He's talking about the possibility of targeting 141% returns in a week when gold itself only moved 1.6%. Now, with global tensions rising, central banks buying gold at unprecedented rates and the recent Fed rate cut, Geof believes we could be entering a major gold supercycle. But he believes most traders will miss the real opportunity here. Want to know why Geof is so excited about gold, yet advising against buying it? You can see his full breakdown here To your prosperity, The Prosperity Pub team The profits and performance shown are not typical, we make no future earnings claims, and you may lose money. The trades expressed are from historical data in order to demonstrate the potential of the system. |
|
|
ABOUT US: We believe that the opportunity for financial literacy and freedom belongs to all people, not just those who already have years of investing experience. Prosperity Pub provides an array of educational services and products that will help you navigate the markets and become a better investor. Trading is made simple through our online forum full of trading techniques to give you the best tools to kick-start your investing journey. We offer collaborative webinars and training; we love to teach. No matter the opportunity, we bring together a strong community of like-minded traders to focus on analyzing market news as it’s presented each day. Unsubscribe |
*Sponsored After an Approximate 1,041% Move in Under 3 Months From a Recent BioPharma Profile, Ou...
No comments:
Post a Comment